Skip to main content
. 2024 Feb 3;51(3):227–242. doi: 10.1007/s10928-023-09898-0

Fig. 8.

Fig. 8

Simulated median brain receptor occupancy kinetics and 90% prediction interval following sequential daily intravenous infusions (60 min) of balovaptan 50 mg, 25 mg, and 15 mg. Solid line: median; shaded area: 90% prediction interval from 2000 simulated participants. Horizontal dashed lines indicate 80% and 95% receptor occupancy